MURAL ONCOLOGY PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.33 USD | -6.98% |
|
-11.67% | -43.75% |
| 04-04 | Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target | MT |
| 01-08 | Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials | CI |
Evolution of the average Target Price on Mural Oncology plc
Price target over the last 5 years
History of analyst recommendation changes
cb3d568f99e.iokOKeARmv3r31UhzKObZ3uc1iwEqr6U4pMFWMQsvOg.4s92GrQi8cuGtTlWie7pHRjQjHtvztKtlf5QHr1A_qC8210apHXjmaeGJg~b3abf037e58b411888972d52851b4f38
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.35
USD
Average target price
13
USD
Spread / Average Target
+288.06%
High Price Target
13
USD
Spread / Highest target
+288.06%
Low Price Target
13
USD
Spread / Lowest Target
+288.06%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Mural Oncology plc
| Morgan Stanley |
Chiffre d''affaires - Rate of surprise
- Stock Market
- Equities
- MURA Stock
- Consensus Mural Oncology plc
